← All trials
NCT07219953
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 16, 2025
- Primary completion
- Apr 30, 2028
- Completion date
- Apr 30, 2028
- First posted
- Oct 22, 2025
- Last posted
- Nov 24, 2025
- Enrollment
- 1100
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.